I am highly experienced in medicinal chemistry and have worked on a diverse set of biological targets over many disease areas in several organisations (Xenova, Argenta Discovery and Summit plc). I have an extensive track record in project and team management, intellectual property, drug discovery in many therapeutic areas and helped lead the chemistry effort directed towards the identification of SMTC1100 (Summit's Duchenne Muscular Dystrophy drug, currently undergoing clinical evaluation).
I have also conducted research at the Alzheimer's Research UK Oxford Drug Discovery Institute and taught at Oxford University (organic chemistry, pharmaceutical chemistry and biomedical sciences). I was a fellow of St Hilda's College, Oxford, between 2015 and 2018.
Lecturer in Organic and Pharmaceutical Chemistry
Organic and medicinal chemistry.
Chemical and biosensors for medical and environmental applications.
Ritchie, James, Sykes, Andy, Weber, Peter and Wren, Stephen P. (2019) Immuno-oncology : the next generation of breakthrough therapies. Highlights from The Society for Medicines Research Symposium. Oxford, UK - June 21, 2019. Drugs of the Future, 44(7), pp. 599-604. ISSN (print) 0377-8282
Wren, Stephen P. (2020) Tricyclic systems : central carbocyclic ring with fused five- and six-membered rings. In: UNSPECIFIED, (ed.) Comprehensive Heterocyclic Chemistry IV. Elsevier. (In Press)